A Trial Evaluating Brelovitug vs Delayed Treatment for the Treatment of Chronic Hepatitis Delta Infection (AZURE-4) (NCT07298330)

🧪 Interventions in This Study

• Brelovitug 300 mg (DRUG)
• Brelovitug 900 mg (DRUG)
• Delayed Treatment with Brelovitug 300mg (DRUG)

Full eligibility criteria are available on the official NIH protocol. View the criteria ↗

📍 All Participating Trial Locations (27 Sites)

Showing the first 25 of 27 sites.

• University of California, Davis — Davis, California
• Kaiser Permanente Medical Center — Sacramento, California
• Quest Clinical Research — San Francisco, California
• Denver Health Medical Center — Denver, Colorado
• Alliance Clinical, Las Vegas — Las Vegas, Nevada
• Cleveland Clinic — Cleveland, Ohio
• Prime Clinical Research Inc — Mansfield, Texas
• University of Utah — Salt Lake City, Utah
• Erasme Hospital — Brussels,
• University Hospital Antwerp (UZA) — Edegem,
• University Hospital Center Sart-Tilman — Liège,
• Acibadem City Clinic University Multiprofile Hospital for Active Treatment Tokuda — Sofia,
• Hospital Service LTD — Kutaisi,
• Diakori LLC — Tbilisi,
• JSC T. Tsertsvadze Infectious Diseases, AIDS and Clinical Immunology Research Center — Tbilisi,
• LTD Academician Vakhtang Bochorishvili Clinic — Tbilisi,
• Central Hospital of Southern Pest National Institute of Hematology and Infectious Diseases — Budapest,
• Fejer County St. Gyorgy University Teaching Hospital — Székesfehérvár,
• Soroka University Medical Center — Beersheba,
• HaEmek Medical Center — Haifa,
• Aga Khan University & Hospital — Karachi, Karachi
• Kaohsiung Medical University Chung-Ho Memorial Hospital — Kaohsiung City,
• E-Da Hospital — Kaohsiung City,
• National Taiwan University Hospital — Taipei,
• Limited Liability Company "Medical Center Health and Rehabilitation "100 Percent Life" — Poltava,

💰 Cost, Insurance & Patient Rights

• 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
• Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
• Voluntary Participation: You may withdraw at any time without affecting your standard medical care.

More studies in Chronic Hepatitis D Infection

• A Trial Evaluating BJT-778 vs Delayed Treatment for the Treatment of Chronic Hepatitis Delta Infection — Garden Grove, California
• A Phase III Study to Evaluate the Efficacy and Safety of Libevitug in Participants With Chronic HDV Infection (D-clear Study) — Garden Grove, California

Explore by condition: All Chronic Hepatitis D Infection clinical trials

💡 How to Participate

1. Check the checklist above to see if you may qualify.
2. Review the official NIH record below to find the coordinating site.
3. Ask about the visit schedule, what is covered at no cost, and any travel support.
4. Confirm with your own doctor before making a decision.